Skip to main content

Elevance Health to Hold Conference Call and Webcast to Discuss Second Quarter Results on July 20, 2022

Elevance Health (NYSE: ELV) will release second quarter 2022 financial results on July 20, 2022, at 6:00 a.m. Eastern Daylight Time (“EDT”). Management will review these results and its outlook during a conference call at 8:30 a.m. EDT that same morning. The conference call should be accessed at least 15 minutes prior to its start with the following numbers:

888-947-9963 (Domestic)

866-430-8797 (Domestic Replay)

312-470-0178 (International)

203-369-0943 (International Replay)

The access code for the call is 3972058. There is no access code for the replay. The replay will be available from 11:30 a.m. EDT on July 20, 2022 until the end of the day on August 20, 2022. The call will also be available through a live webcast at www.elevancehealth.com under the “Investors” link. A webcast replay will be available following the call.

About Elevance Health, Inc.

Elevance Health is a lifetime, trusted health partner fueled by its purpose to improve the health of humanity. The company supports consumers, families, and communities across the entire care journey – connecting them to the care, support, and resources they need to lead healthier lives. Elevance Health’s companies serve more than 118 million people through a diverse portfolio of industry-leading medical, digital, pharmacy, behavioral, clinical, and complex care solutions. For more information, please visit www.elevancehealth.com or follow us @ElevanceHealth on Twitter and Elevance Health on LinkedIn.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  209.26
+4.40 (2.15%)
AAPL  264.20
+3.62 (1.39%)
AMD  199.29
-4.08 (-2.01%)
BAC  52.78
+0.01 (0.02%)
GOOG  315.46
+11.90 (3.92%)
META  654.99
+10.21 (1.58%)
MSFT  396.89
-1.57 (-0.39%)
NVDA  189.22
+1.32 (0.70%)
ORCL  147.68
-8.86 (-5.66%)
TSLA  409.68
-2.03 (-0.49%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.